# MyHealthTeams

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/myhealthteams

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.myhealthteams.com
- Total disclosed funding: $27M
- Latest round: Series B (Aug 15, 2019)
- Investors on record: 9

## About

MyHealthTeams, Inc. is a US-based digital health company dedicated to enhancing the lives of individuals managing chronic health conditions through specialized social networks that foster community and support.MyHealthTeams, Inc. is engaged in providing digital health solutions aimed at improving the quality of life for individuals managing chronic conditions. Founded in 2012 and headquartered in San Francisco, US, the company has completed six deals with its most recent funding round being Series B in January 2025, where it raised USD 9.44 mn led by UCB Ventures. The company was founded by Eric Peacock and Mary R, with Eric Peacock serving as CEO.MyHealthTeams specializes in digital health solutions designed to assist individuals in managing chronic health conditions. The company offers a suite of social networks tailored to specific health conditions, facilitating peer connections, experience sharing, and access to relevant resources. These platforms enhance community engagement and support, helping users navigate their health journeys with real-time information and shared personal narratives. MyHealthTeams primarily serves patients with conditions like diabetes and mental health disorders, boasting a user base across the US and extending to select international markets, including Canada and the United Kingdom.MyHealthTeams generates revenue through subscription models and collaborations with healthcare organizations. Clients, including pharmaceutical companies and health insurers, partner with MyHealthTeams to utilize the platform for outreach and supportive initiatives. Engagement strategies are tailored for specific user demographics, supported by sponsorship opportunities within their health-focused networks, allowing brands to connect directly with end-users. While specific pricing plans are not available, the company's platforms offer a framework for monetization through value-added services and enhanced visibility for health-related products and initiatives.In January 2025, MyHealthTeams was acquired by Swoop Inc., which enables the latter to bolster its market presence. Future growth strategies may include the development of new products and expansion into additional geographic regions, although specific upcoming products and targeted markets have not been disclosed. The recent funding raised during the Series B round will be utilized to support these strategic initiatives.

## Funding rounds

- Series B, Aug 15, 2019, $9.4M — Adams Street Partners, Qiming Venture Partners, The Westly Group, 500 Global, HealthTech Capital, CVS Health Corporation, UCB Ventures
- Series C, Jun 12, 2017, $7.3M — Adams Street Partners, Qiming Venture Partners, The Westly Group, 500 Global, HealthTech Capital, CVS Health Corporation
- Series B, Oct 29, 2015, $5M — Adams Street Partners, The Westly Group, Sand Hill Angels, HealthTech Capital, CVS Health Corporation
- Series A, Feb 12, 2014, $3.4M — Adams Street Partners, The Westly Group, 500 Global, Sand Hill Angels, HealthTech Capital, TSVC
- Seed, Aug 14, 2012, $1.8M — Adams Street Partners, 500 Global

## Investors

- Adams Street Partners (https://capitalatlas.ai/funds/adams-street-partners) — Seed, Series A, Series B, Series C
- 500 Global (https://capitalatlas.ai/funds/500-global) — Seed, Series A, Series C, Series B
- The Westly Group (https://capitalatlas.ai/funds/the-westly-group) — Series A, Series B, Series C
- Sand Hill Angels (https://capitalatlas.ai/funds/sand-hill-angels) — Series A, Series B
- HealthTech Capital — Series A, Series B, Series C
- TSVC (https://capitalatlas.ai/funds/tsvc) — Series A
- CVS Health Corporation — Series B, Series C
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series C, Series B
- UCB Ventures (https://capitalatlas.ai/funds/ucb-ventures) — Series B